March 25, 2015 / 12:27 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Kraft Foods, Kofax, Apollo Education

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were little changed in light volume on Wednesday ahead of industrial orders data, with deals indicating investors still see value in the market despite indexes trading near all time highs. Dow Jones industrial average e-mini futures were down 0.11 percent at 17,930, S&P 500 e-mini futures were down 0.01 percent at 2,084.75 and Nasdaq 100 e-mini futures were up 0.06 percent at 4,431.5.

** KRAFT FOODS GROUP INC, Tuesday close $61.325, +34.77 pct premarket

The maker of Velveeta cheese and Oscar Mayer meats will merge with ketchup maker H.J. Heinz Co, owned by 3G Capital and Berkshire Hathaway Inc, to form North America's third-largest food and beverage company.

** KOFAX LTD, Tuesday close $7.5, +45.87 pct premarket

** LEXMARK INTERNATIONAL INC, Tuesday close $40.79, +7.87 pct premarket

Lexmark, known for its printers, said it would buy Kofax in an about $1 billion deal that would double the size of its enterprise software business.

** APOLLO EDUCATION GROUP INC, Tuesday close $27.99, -17.72 pct premarket

The for-profit education provider reported a 14 percent fall in quarterly revenue as it enrolled fewer students. Revenue fell for the fifteenth straight quarter to $578.6 million from $672.8 million.

** NATIONSTAR MORTGAGE HOLDINGS INC, Tuesday close $31.14, -7.68 pct premarket

The mortgage servicer said it is offering 17.5 mln shares, which represents about 19 percent of the company's outstanding stock.

** VBL THERAPEUTICS, Tuesday close $5.5853, +18.17 pct premarket

The Israel-based company said a mid-stage study of its experimental brain cancer drug met the main goal of increasing overall survival.

** ONCOLYTICS BIOTECH INC, Tuesday close $0.789, +20.41 pct premarket

The European Medicines Agency granted orphan drug designation to the company's lead drug, Reolysin, to treat patients with ovarian cancer.

** TESLA MOTORS INC, Tuesday close $201.72, -2.09 pct premarket

Brokerage CLSA downgraded the stock to "underperform" from "outperform" and cut price target to $220 from $275, according to Theflyonthewall.com.

** MERCK INC, Tuesday close $58.63, +1.67 pct premarket

The drugmaker said its board authorized an additional share repurchase of up to $10 billion of the company's common stock. (Compiled By Manya Venkatesh in Bengaluru; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below